Kantoff Philip W. has filed 4 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 123500 shares of Context Therapeutics Inc. ($CNTX) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Context Therapeutics Inc. | $CNTX | Kantoff Philip W. | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| June 13, 2024 | Context Therapeutics Inc. | $CNTX | Kantoff Philip W. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 15,966,053 | 9999.99% | 0.16% |
| March 25, 2024 | ESSA Pharma Inc. | $EPIX | Kantoff Philip W. | Not found | A | Options | 50000 | $0.00 | 50,000.0000 | 44,129,491 | 9999.99% | 0.11% |
| May 31, 2023 | Context Therapeutics Inc. | $CNTX | Kantoff Philip W. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |